- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.18 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x 065: (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(2S,3R)-3-HYDROXY-4-(N-ISOBUTYLBENZO[D][1,3]DIOXOLE-5-SULFONAMIDO)-1-PHENYLBUTAN-2-YLCARBAMATE(Non-covalent)
- 6 x IMD: IMIDAZOLE(Non-covalent)
IMD.2: 4 residues within 4Å:- Chain A: L.99
- Chain B: P.1
- Ligands: ZN.5, CL.11
No protein-ligand interaction detected (PLIP)IMD.3: 3 residues within 4Å:- Chain A: Y.14, E.65
- Ligands: ZN.7
No protein-ligand interaction detected (PLIP)IMD.13: 3 residues within 4Å:- Chain B: E.21
- Ligands: IMD.14, ZN.17
No protein-ligand interaction detected (PLIP)IMD.14: 5 residues within 4Å:- Chain B: R.8, V.10, E.21
- Ligands: IMD.13, ZN.17
1 PLIP interactions:1 interactions with chain B- Water bridges: B:R.8
IMD.15: 7 residues within 4Å:- Chain B: D.30, I.46, M.76
- Ligands: ZN.18, ZN.22, CL.23, CL.24
1 PLIP interactions:1 interactions with chain B- Water bridges: B:K.45
IMD.16: 5 residues within 4Å:- Chain B: W.6
- Ligands: ZN.19, CL.26, CL.27, CL.28
1 PLIP interactions:1 interactions with chain B- pi-Stacking: B:W.6
- 11 x ZN: ZINC ION(Non-covalent)(Non-functional Binders)
ZN.4: 3 residues within 4Å:- Chain A: D.30
- Ligands: 065.1, CL.9
4 PLIP interactions:1 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: A:D.30, H2O.1, H2O.1, H2O.1
ZN.5: 3 residues within 4Å:- Chain A: L.99
- Ligands: IMD.2, CL.11
3 PLIP interactions:1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:L.99, H2O.1, H2O.1
ZN.6: 1 residues within 4Å:- Chain A: D.79
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.79, A:D.79, H2O.1, H2O.1
ZN.7: 2 residues within 4Å:- Chain A: E.65
- Ligands: IMD.3
2 PLIP interactions:1 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:E.65, H2O.1
ZN.8: 2 residues within 4Å:- Chain A: E.63
- Ligands: CL.10
2 PLIP interactions:1 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:E.63, H2O.1
ZN.17: 3 residues within 4Å:- Chain B: E.21
- Ligands: IMD.13, IMD.14
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.21, B:E.21
ZN.18: 5 residues within 4Å:- Chain B: D.30
- Ligands: 065.1, IMD.15, ZN.22, CL.24
2 PLIP interactions:1 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.30, H2O.4
ZN.19: 4 residues within 4Å:- Ligands: IMD.16, CL.26, CL.27, CL.28
No protein-ligand interaction detected (PLIP)ZN.20: 2 residues within 4Å:- Chain B: E.65
- Ligands: CL.25
3 PLIP interactions:1 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.65, H2O.4, H2O.4
ZN.21: 1 residues within 4Å:- Chain B: E.58
3 PLIP interactions:1 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.58, H2O.4, H2O.7
ZN.22: 4 residues within 4Å:- Chain B: D.29, D.30
- Ligands: IMD.15, ZN.18
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.30, B:D.30, H2O.4, H2O.4
- 9 x CL: CHLORIDE ION(Non-functional Binders)
CL.9: 2 residues within 4Å:- Chain A: D.30
- Ligands: ZN.4
Ligand excluded by PLIPCL.10: 3 residues within 4Å:- Chain A: E.63, K.70
- Ligands: ZN.8
Ligand excluded by PLIPCL.11: 3 residues within 4Å:- Chain A: L.99
- Ligands: IMD.2, ZN.5
Ligand excluded by PLIPCL.23: 3 residues within 4Å:- Chain B: K.45, I.46
- Ligands: IMD.15
Ligand excluded by PLIPCL.24: 5 residues within 4Å:- Chain B: V.47, G.48
- Ligands: 065.1, IMD.15, ZN.18
Ligand excluded by PLIPCL.25: 3 residues within 4Å:- Chain B: G.17, E.65
- Ligands: ZN.20
Ligand excluded by PLIPCL.26: 8 residues within 4Å:- Chain B: S.4, L.5, W.6, K.7
- Ligands: IMD.16, ZN.19, CL.27, CL.28
Ligand excluded by PLIPCL.27: 6 residues within 4Å:- Chain B: W.6, K.7
- Ligands: IMD.16, ZN.19, CL.26, CL.28
Ligand excluded by PLIPCL.28: 5 residues within 4Å:- Chain B: K.7
- Ligands: IMD.16, ZN.19, CL.26, CL.27
Ligand excluded by PLIP- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kovalevsky, A.Y. et al., Structural evidence for effectiveness of darunavir and two related antiviral inhibitors against HIV-2 protease. J.Mol.Biol. (2008)
- Release Date
- 2008-09-16
- Peptides
- Protease: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.18 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x 065: (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(2S,3R)-3-HYDROXY-4-(N-ISOBUTYLBENZO[D][1,3]DIOXOLE-5-SULFONAMIDO)-1-PHENYLBUTAN-2-YLCARBAMATE(Non-covalent)
- 6 x IMD: IMIDAZOLE(Non-covalent)
- 11 x ZN: ZINC ION(Non-covalent)(Non-functional Binders)
- 9 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kovalevsky, A.Y. et al., Structural evidence for effectiveness of darunavir and two related antiviral inhibitors against HIV-2 protease. J.Mol.Biol. (2008)
- Release Date
- 2008-09-16
- Peptides
- Protease: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B